The Scoping Study, and supposed Offtake Agreement has absolutely nothing to do with " Assay delays". The Ore has already returned the dreamed of Purities.
The ongoing problem for this Company. And this resource. And the plethora of others like it is, that there is no DSO market for it. Most certainly the case from a HPA perspective, and will remain so until until such times as at least One entity anywhere on this Planet starts to commercially produce HPA from Ores such as these. Presently the technology/processes for doing so are not proven at anything beyond Desk Top study levels.
Further to the afore stated., I can assure you that the Entities that are progressing this Technology., Are not now, nor ever will be looking at White Dams in WA for Processing Material. They have Hundreds of years of material (10ktpa end product), sitting on the surface, in Aus., Already at JORC compliant Measured status, readily adjacent infrastructure and Port facility's.
"Do yourself a favour and make contact with Tony and hear what he has to say and you’ll be whistling a very different tune".
I have never known a Company Director to openly admit a single negative relative to the prospects of the potential growth of their Companies. Make of that as you will.
- Forums
- ASX - By Stock
- CR9
- Ann: Maiden Mineral Resource Estimate of 24.7Mt for Tampu Project
Ann: Maiden Mineral Resource Estimate of 24.7Mt for Tampu Project, page-93
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CR9 (ASX) to my watchlist
|
|||||
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.116M |
Open | High | Low | Value | Volume |
1.1¢ | 1.1¢ | 1.1¢ | $1K | 90.90K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 194318 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 829988 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 194318 | 0.010 |
4 | 875461 | 0.009 |
3 | 620000 | 0.008 |
2 | 590000 | 0.007 |
1 | 250000 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 829988 | 3 |
0.016 | 126983 | 1 |
0.020 | 24871 | 1 |
0.026 | 500000 | 1 |
0.027 | 56338 | 1 |
Last trade - 10.02am 15/07/2024 (20 minute delay) ? |
Featured News
CR9 (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online